{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:45:08Z","timestamp":1793853908942,"version":"4.6.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ajogmf.2024.101565","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T12:40:39Z","timestamp":1732797639000},"page":"101565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Vaginal progesterone for prevention of preterm birth in women with a history of preterm birth regardless of cervical length: an argument for use"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8055-1210","authenticated-orcid":false,"given":"Charlette E.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3705-6943","authenticated-orcid":false,"given":"Rupsa C.","family":"Boelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2024.101565_bib0009","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.AOG.0000270112.05025.1d","article-title":"Gestational age at cervical length measurement and incidence of preterm birth","volume":"110","author":"Berghella","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.semperi.2009.06.007","article-title":"Prediction of preterm birth: cervical sonography","volume":"33","author":"Mella","year":"2009","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0011","article-title":"Prevention of preterm birth by progestational agents: what are the molecular mechanisms?","volume":"208","author":"Nold","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.010","article-title":"Vaginal progesterone, but not 17\u03b1-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface","volume":"213","author":"Furcron","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0014","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/uog.5159","article-title":"Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"DeFranco","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/uog.7338","article-title":"Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial","volume":"34","author":"O'Brien","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2024.101351","article-title":"Concurrent progestogen and cerclage to Reduce preterm birth: a multicenter international retrospective cohort","volume":"6","author":"Tolosa","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101215","article-title":"Vaginal progesterone should be offered to patients with a singleton gestation and a history of spontaneous preterm birth only if a cervical length \u226425 mm is detected at midtrimester","volume":"6","author":"Conde-Agudelo","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101116","article-title":"Vaginal progesterone for the prevention of recurrent spontaneous preterm birth","volume":"5","author":"Berghella","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0019","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ajog.2022.07.054","article-title":"Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester cervical length >25 mm","volume":"227","author":"Conde-Agudelo","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0021","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","article-title":"Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial","volume":"387","author":"Norman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.05.022","article-title":"Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth","volume":"217","author":"Ning","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0023","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.healthpol.2018.02.002","article-title":"No-shows in appointment scheduling \u2013 a systematic literature review","volume":"122","author":"Dantas","year":"2018","journal-title":"Health Policy"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0024","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/152460900750020928","article-title":"The no-show rate in a high-risk obstetric clinic","volume":"9","author":"Campbell","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/ajo.12586","article-title":"Implementing universal cervical length screening in asymptomatic women with singleton pregnancies: challenges and opportunities","volume":"57","author":"Pedretti","year":"2017","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0026","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40168-016-0223-9","article-title":"The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk","volume":"5","author":"Kindinger","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0027","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0002-9378(99)70267-X","article-title":"Cervical length in uncomplicated pregnancy: a study of sociodemographic predictors of cervical changes across gestation","volume":"180","author":"Dijkstra","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0028","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajog.2015.10.934","article-title":"Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety","volume":"214","author":"O'Brien","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.06.014","article-title":"Progesterone inhibits in vitro fetal membrane weakening","volume":"213","author":"Kumar","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101565_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001431.pub4","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"1","author":"Stacey","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258993332400291X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258993332400291X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:17:20Z","timestamp":1762633040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258993332400291X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S258993332400291X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101565","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal progesterone for prevention of preterm birth in women with a history of preterm birth regardless of cervical length: an argument for use","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101565"}}